SHARE:   Share to Facebook Share to Twitter Share to Linked In Share via Email  

Back To Search Results

S41 - Neuro-oncology

Event Time: Thursday April 27, 2017 1:00 pm to 3:00 pm
Topic(s): Neuro-oncology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Program Speakers - Tentative

Start/End Time Title Faculty
2:35 PM - 3:00 PM Discussion Lakshmi Nayak MD 

Disclosures

Speaker Disclosure
Lakshmi Nayak, MD Dr. Nayak has nothing to disclose.

Abstract Presenters

Start Time Pub. Title Presenter
1:24 PM 003 Clinical and molecular characteristics of glioneuronal tumors Julie Miller, MD
Disclosure:
Dr. Miller has nothing to disclose.

1:36 PM 004 Tumor stem cell RNA-loaded dendritic cell vaccine for recurrent glioblastoma: a phase 1 trial Anastasie Dunn-Pirio, MD
Disclosure:
Dr. Dunn-Pirio has nothing to disclose.

1:48 PM 005 Targeting carcinoma–astrocyte gap junctions in brain metastasis Adrienne Boire, MD
Disclosure:
Dr. Boire has nothing to disclose.

2:00 PM 006 Identification of clinically actionable PI3K pathway mutations in brain metastases from breast cancer Ugonma Chukwueke, MD
Disclosure:
Dr. Chukwueke has nothing to disclose.

2:12 PM 007 Microtubule Associated Protein (MAP) 1B: Antigen of PCA-2 IgG, Biomarker of Small-Cell Lung Carcinoma-related Paraneoplastic Neurological Autoimmunity Avi Gadoth
Disclosure:
,,,Mayo Foundation has applied for a patent relating to commercial testing for MAP1B autoantibody that is the subject of this report.,,,

Dr. Gadot has received royalty payments from Mayo Foundation.

2:24 PM 008 Germline genetic mutations contribute to the development of primary brain tumors: a review of a multigene panel testing cohort Amanda Bergner
Disclosure:
Dr. Bergner has received personal compensation for activities with Ambry Genetics as an employee. Dr. Bergner has received royalty payments from UpToDate.

Register Now

Related Courses

Sunday April 22, 2018

9:15 AM-12:00 PM
PL2 Presidential Plenary Session

Wednesday April 25, 2018

1:00 PM-3:00 PM
C148 Neurologic Consultations in Cancer Patients I Amy Pruitt MD
3:30 PM-5:30 PM
C163 Neurologic Consultations in Cancer Patients II Patrick Wen MD, FAAN

Thursday April 26, 2018

7:00 AM-9:00 AM
C177 Neuro-oncology in 2018: Navigating Current Trends Maciej Mrugala MD
1:00 PM-3:00 PM
C189 Neuro-oncologic Predicaments in the Hospital Setting Na Tosha Gatson MD, PhD
3:30 PM-5:30 PM
N6 Neuroscience in the Clinic: Neurologic Complications of Cancer Immunotherapy: A New Frontier in Neuro-Inflammation Antonio Omuro MD,
Andreas Hottinger MD

MEMBER LOG IN

Forgot Password?